Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Journal of the American College of Cardiology
|
October 14, 2008
Hypertension, heart failure, and beta-adrenergic blocking drugs
Michael B Fowler
The American Journal of Cardiology
|
May 18, 2004
Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol in severe heart failure
Michael B Fowler
Heart Failure Clinics
|
March 28, 2007
Cardiomyopathy of insulin resistance
Ronald M Witteles, Michael B Fowler
Journal of the American College of Cardiology
|
January 15, 2008
Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options
Ronald M Witteles, Michael B Fowler
Annals of Internal Medicine
|
December 8, 2004
B-type natriuretic peptide is effective therapy before care
Ronald Witteles, Kelly Matsuda, Michael B Fowler
Heart Failure Clinics
|
July 14, 2011
Chemotherapy-associated cardiotoxicity: how often does it really occur and how can it be prevented?
Ronald M Witteles, Michael B Fowler, Melinda L Telli
Progress in Cardiovascular Nursing
|
June 2, 2007
Why do we need to prevent right ventricular pacing?
Angela Tsiperfal, Kimberly Scheibly, Michael B Fowler, et al.
Journal of the American College of Cardiology
|
December 19, 2006
Emerging therapies for the management of decompensated heart failure: from bench to bedside
Emil M deGoma, Randall H Vagelos, Michael B Fowler, et al.
Current Medical Research and Opinion
|
February 10, 2006
The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysis
David S H Bell, Mary Ann Lukas, Frederick K Holdbrook, et al.
American Heart Journal
|
November 4, 2004
Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure
W H Wilson Tang, Randall H Vagelos, Yin-Gail Yee, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Journal of the American College of Cardiology
|
October 14, 2008
Hypertension, heart failure, and beta-adrenergic blocking drugs
Michael B Fowler
The American Journal of Cardiology
|
May 18, 2004
Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol in severe heart failure
Michael B Fowler
Heart Failure Clinics
|
March 28, 2007
Cardiomyopathy of insulin resistance
Ronald M Witteles, Michael B Fowler
Journal of the American College of Cardiology
|
January 15, 2008
Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options
Ronald M Witteles, Michael B Fowler
Annals of Internal Medicine
|
December 8, 2004
B-type natriuretic peptide is effective therapy before care
Ronald Witteles, Kelly Matsuda, Michael B Fowler
Heart Failure Clinics
|
July 14, 2011
Chemotherapy-associated cardiotoxicity: how often does it really occur and how can it be prevented?
Ronald M Witteles, Michael B Fowler, Melinda L Telli
Progress in Cardiovascular Nursing
|
June 2, 2007
Why do we need to prevent right ventricular pacing?
Angela Tsiperfal, Kimberly Scheibly, Michael B Fowler, et al.
Journal of the American College of Cardiology
|
December 19, 2006
Emerging therapies for the management of decompensated heart failure: from bench to bedside
Emil M deGoma, Randall H Vagelos, Michael B Fowler, et al.
Current Medical Research and Opinion
|
February 10, 2006
The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysis
David S H Bell, Mary Ann Lukas, Frederick K Holdbrook, et al.
American Heart Journal
|
November 4, 2004
Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure
W H Wilson Tang, Randall H Vagelos, Yin-Gail Yee, et al.
Page
of 4